Immunoadsorption as a new treatment option for patients with idiopathic dilated cardiomyopathy

Abstract

Get full access to this article

View all access options for this article.

References

Zannad F , Briancon S , Juilliere Y. Incidence, clinical and etiologic features, and outcome of advanced chronic heart failure: the EPICAL study . J Am Coll Cardiol 1999; 33: 734-742 .

Eurotransplant International Foundation . Annual report 1998. Eurotransplant International Foundation , 1998.

Wallukat G , Müller J , Podlowski S , Nissen E , Morwinski R , Hetzer R. Agonist-like beta-adrenoceptor antibodies in heart failure . Am J Cardiol 1999; 83: 75H-79H .

Jahns R , Boivin V , Siegmund C , Inselmann G , Lohse M , Boege F. Autoantibodies activating human β1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure . Circulation 1999; 99: 649-654 .

Staudt A , Spielhagen T , Dörffel W et al. Removal of cardiodepressant factor(s) in dilated cardiomyopathy by immunoadsorption [Abstract] . Eur Soc Cardiol 1999; P3400-P3400 .

Wallukat G , Fu H-M , Matsui S , Hjalmarson A , Fu M. Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display nondesensitized agonist-like effects . Life Sci 1999; 64: 465-469 .

Dörffel W , Felix S , Wallukat G et al. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy , Circulation 1997; 95: 1994-1997 .

Müller J , Wallukat G , Dandel M. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy . Circulation 2000; 101: 385-391 .